NITN | @notintownlive | 22 Apr 2022, 07:16 am

Bengaluru: South India’s diversified Sona Group has forged a 50:50 joint venture with Australia’s Mycelium Biotechnology Group to set up a state-of-the art Mycelium research and production facility in Salem.
Mycelium Biotechnology is an Australian group known for pioneering innovative solutions to optimise human and planetary health, using mycelium and other extracts from Mushrooms, an abundantly available and sustainable natural resource.
As a global mushroom biotechnology group, Mycelium Biotechnology is engaged in mushroom growing, global distribution and offering biotechnology and nutraceuticals solutions through global partners.
According to Chocko Valliappa, Vice Chairman of The Sona group, “We are happy to forge the Mycelium Sona Biotech joint venture with Australia’s Mycelium Biotechnology, a research focused world leader in Mycelium based products and solution provider.
The partnership will leverage Sona Group’s research and innovation framework to add to the vast range of IP and patentable technologies.”
The JV named as Mycelium Sona Biotech (MSB) has set up a research facility at Salem to focus on Nanotech Research, IP development, Extract Manufacturing, Milling, Bottling and eCommerce. Billed as one of the largest mushrooms laboratories in India at Salem with best Global Manufacturing Practices, MSB laboratory will research and grow high end mushrooms, extract Mushroom and Mycelium compounds, produce nutraceuticals that conform to FSSAI and FDA certification.
“We see great opportunity in the Indian market moving forward. Sona’s background in health tech and research development is a perfect partnership for us to further advance our nano compound extraction IP.
The launch of the first MSB facility in Salem comes at the most opportune time soon after signing of the Free Trade Agreement between Australia and India” says William Scott, Chairman of Mycelium Biotechnology group.
With R&D, Business and Distribution centres located across Australia’s East Coast as well as manufacturing facilities in Wisconsin (USA), Mycelium Biotechnology owns scores of IP.
The bulk of this IP relates to cultivation methods and associated medium formulations for nearly 20 mushroom species, extraction processes of mushroom and mycelium biomass and formulations of mushroom extracts.
The medicinal mushroom industry is expected to grow exponentially as more and more of the 5.1 million mushroom species are researched.
The global fungi industry is forecast to exceed USD $86B by 2025, up from $53.7B in 2019. Growth will be powered in part by culinary demand, but an even larger driver will be rising adoption by the pharmaceutical industry.
Varieties such as Chaga, not ever seen on a dinner plate, are now in the supplement spotlight. www.thesonagroup.com
Some of the key portfolio companies expanding through the joint-venture include:
REMbiotics, one of the divisions of Mycelium Biotechnology, addresses the global issue of depression (MDD, TRD, PTSD) using specific mushroom mycelium bioactive compounds combined with Australian native bush foods for a beneficial and synergistic effect. www.rembiotics.com
Preotica is an evolutionary life sciences company that has been focusing on enhancing animal immunity and microbial health.
Utilising mycelium biotechnology extraction processes, the Preotica product has been able to produce some remarkable results, specifically in the poultry industry, aquaculture industry and for beekeepers across Australia. www.preotica.com.
Shroompac focuses on mushroom and mycelium-derived sustainable eco-packaging materials for industrial and consumer applications.
- Narendra Modi in Tianjin: India, China to resume direct flights as ties improve at SCO summit
- 'Change is imminent, embrace the reality': Education sector stares at transformation in age of AI
- Global Collaboration Forum, IIM Calcutta Innovation Park ink MoU to support startups ahead of London summit
- USA: Santoor Ashram Kolkata mesmerises Los Angeles with a celebration of Indian classical music
- India Setu curtain raiser showcases AI, healthcare, and conservation as drivers of global collaboration
- Feminist pioneer Abala Bose was both a subscriber and critique of colonial ideas: Author Saptarshi Mallick
- Rotary Club of Belur strengthens Kolkata healthcare with donation to Ramkrishna Mission Seva Pratishthan
- India Humanity Foundation launches “Padho Bharat 2025” literacy campaign
- Kolkata: Mega health camp transforms lives in Ultadanga slum with free multi-specialty services
- 'Music Meets Bells' returns: New York to witness divine confluence of sound and movement
Akasa Air has announced the addition of Kozhikode (Calicut) as its 30th destination and 24th domestic stop.
Air New Zealand has announced plans to host a live inflight concert, ‘SYNTHONY in the Sky’, on Dec 4 aboard Flight NZ1331 from Auckland to Sydney.
Qatar Airways will move its New York operations to The New Terminal One at John F. Kennedy International Airport (JFK) in 2026. As part of the relocation, the airline plans to open a 15,000-square-foot lounge, its first dedicated facility in both New York City and the United States.